Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasms 15Endometrial Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Melanoma 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Osteosarcoma 2Locally Advanced Rectal Cancer (LARC) 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Carcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Capecitabine 41Oxaliplatin 39Fluorouracil 29Leucovorin 23Radiotherapy 21Cetuximab 14Bevacizumab 14Irinotecan 13Nivolumab 12Magnetic Resonance Spectroscopy 11Specimen Handling 9Surgical Procedures, Operative 8Folfox protocol 8Drug Therapy 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Chemoradiotherapy 7Biopsy 7trifluridine tipiracil drug combination 6Radiation 6tislelizumab 5sintilimab 5regorafenib 5dehydroftorafur 5X-Rays 5Surveys and Questionnaires 5Sigmoidoscopy 5Endoscopy 5Consolidation Chemotherapy 5spartalizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Rectal Neoplasms × dostarlimab × 1 year × Clear all
NCT05723562 2026-05-26

AZUR-1

GlaxoSmithKline

Phase 2 Active not recruiting
154 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04165772 2026-05-13

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
212 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06640049 2025-11-17

China AZUR-1

GlaxoSmithKline

Phase 2 Active not recruiting
23 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04926324 2025-06-29

A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

University of Iowa

Phase 1/2 Terminated
3 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡